Microtech, a subsidiary of Tel Aviv-based Medinol Inc., announced on Thursday the launch of human clinical trials for its microsensor platform aimed at improving heart failure treatment.
The first successful implantation of the device was recently performed by Prof. Erez Sharoni at Beilinson Medical Center in Petah-Tikva.
Utilizing external ultrasound communication, the microsensor enables current implants to function as smart devices, capable of gathering real-time data and performing multiple functions simultaneously.
“This amazing technology may change the standard of care for patients suffering from heart failure and in particular, in this current study, those who are receiving LVADs or heart transplants,” said Sharoni.